Entero Therapeutics Inc.
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 10 institutions reported holding Entero Therapeutics Inc. in their 13F filings, up 2 from Q1 2025. 4 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($15K), UBS Group AG ($8K) and Two Sigma Securities, LLC ($6K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Entero Therapeutics Inc.
- CUSIP
- 33749P408
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $21K |
| Exits | 2 | $18K |
All 13F filers, Q1 2025 → Q2 2025: 53,423 shares bought and 76,030 shares sold, net −22,607 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Geode Capital Management, LLC | 0.00% | No change | 36,560 | $15K |
| UBS Group AG | 0.00% | Reduce -64.5% | 20,553 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 15,776 | $6K |
| Jane Street Group, LLC | 0.00% | New | 12,730 | $5K |
| Renaissance Technologies | 0.00% | New | 12,500 | $5K |
| Citadel Advisors | 0.00% | New | 12,415 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.1% | 5,064 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 3,307 | $1K |
| Bank of America Corp. | 0.00% | Add +5.0% | 42 | $17 |
| US Bancorp \de | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ENTERO THERAPEUTICS INC's weight in each manager's 13F, not the share of Entero Therapeutics Inc. the manager owns.